Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value (50% above current price).
Rating: 4 stars
Uncertainty rating: Medium
Moat: Narrow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.